Literature DB >> 9731565

Retinoic acid treatment induces apoptosis or expression of a more differentiated phenotype on different fractions of cultured fetal rat hepatocytes.

L Falasca1, A Favale, G Gualandi, G Maietta, L Conti Devirgiliis.   

Abstract

The present study reports the effects of retinoic acid (RA) on cultured fetal rat hepatocytes. We show that RA treatment induces both differentiation and apoptosis. Hepatocytes cultured for 48 hours in the presence of 5 microl/L RA form junctional complexes in the areas of contact between neighboring cells and develop bile canaliculi, typical features of mature and well-differentiated cells. At the same time, about 20% of cells are induced to die by apoptosis, and the percentage of apoptotic cells increases according to the concentration of RA used and the duration of treatment. The induction of apoptosis, studied at the morphological and biochemical levels, revealed that, in our system, the classical compaction of chromatin occurs only during the final stages of the process; instead of the common marker of apoptosis, i.e., the "DNA ladder" pattern of fragmentation, megabase-sized fragments were found. These observations provide further evidence of the existence of fundamental differences in the mechanisms of apoptosis among cell types. To investigate the molecular mechanism of the effects of RA, we evaluated the expression of two proteins, c-myc and p53, which are known to be involved in both cell differentiation and apoptosis. The data obtained show that the amount of p53 remained unchanged after RA treatment. On the contrary, a dose-dependent reduction in c-myc levels was found, suggesting that RA action may be mediated by modulation of this oncogene. Our findings regarding the apoptosis-inducing effect of RA, which was not found in adult hepatocytes, suggest a possible relationship between this phenomenon and the proliferative capacity and/or differentiation state of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731565     DOI: 10.1002/hep.510280319

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

Review 1.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  All-trans retinoic acid down-regulates human albumin gene expression through the induction of C/EBPbeta-LIP.

Authors:  Takahiro Masaki; Tomokazu Matsuura; Kiyoshi Ohkawa; Tatsuo Miyamura; Isao Okazaki; Tetsu Watanabe; Tetsuro Suzuki
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

3.  Retinoic acid regulates cell cycle genes and accelerates normal mouse liver regeneration.

Authors:  Hui-Xin Liu; Irene Ly; Ying Hu; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2014-08-01       Impact factor: 5.858

4.  Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition.

Authors:  Yan Yang; Shu-Kui Qin; Qiong Wu; Zi-Shu Wang; Rong-Sheng Zheng; Xu-Hui Tong; Hao Liu; Liang Tao; Xian-Di He
Journal:  Oncol Rep       Date:  2013-12-05       Impact factor: 3.906

5.  Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma.

Authors:  Rajni Kant; Chia-Hung Yen; Jung-Hsien Hung; Chung-Kuang Lu; Chien-Yi Tung; Pei-Ching Chang; Yueh-Hao Chen; Yu-Chang Tyan; Yi-Ming Arthur Chen
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

6.  Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.

Authors:  Linchao Ding; Shilong Ning; Weijian Hu; Yadong Xue; Shi'an Yu
Journal:  Oxid Med Cell Longev       Date:  2022-09-19       Impact factor: 7.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.